Markets:

Overview

News

Currencies

International

Treasuries

Lantern Pharma Inc. - Common Stock (NQ:LTRN)

1.473 +0.233 (+18.77%)

Streaming Delayed Price Updated: 11:15 AM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantern Pharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021

October 04, 2021

RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be...

From MicroCap Rodeo

Via AccessWire

Lantern Pharma to Present at Microcap Rodeo's Fall Harvest - Best Ideas from the Buy-Side on Wednesday, October 6, 2021

September 30, 2021

DALLAS, TX / ACCESSWIRE / September 30, 2021 / Lantern Pharma (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to...

From Lantern Pharma

Via AccessWire

Topics Artificial Intelligence

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Lantern Pharma's LP-184 Receives Orphan Drug Tag For Brain Cancer Indication ↗

August 30, 2021

The FDA has granted Orphan Drug Designation to Lantern Pharma Inc's (NASDAQ: LTRN) LP-184 for glioblastoma multiforme (GBM) and other malignant gliomas. The news follows the...

Via Benzinga

54 Biggest Movers From Yesterday ↗

August 26, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Preclinical Data Of Brain Tumor Candidate Fails To Lift Lantern Pharma Stock ↗

August 19, 2021

Lantern Pharma Inc (NASDAQ: LTRN) announced preclinical data of its drug candidate LP-184, showing its potential to inhibit tumor growth and improve survival in...

Via Benzinga

Lantern Pharma Secures FDA Orphan Drug Tag For Pancreatic Cancer Candidate ↗

August 11, 2021

The FDA has granted Orphan Drug Designation to Lantern Pharma Inc's (NASDAQ: LTRN) LP-184 for pancreatic cancer. LP-184 is a small molecule drug...

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Following Friday's Rally ↗

July 26, 2021

Pre-open movers U.S. stock futures traded lower in early pre-market trade after all three major indexes settled at record highs in the previous session. China announced a set of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 21, 2021

Gainers Chembio Diagnostics (NASDAQ:CEMI) stock rose 189.72% to $5.97 during Wednesday's regular session. Trading volume for Chembio Diagnostics's stock is 265.3...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Lantern Pharma Shares Moves Higher On Encouraging Data From Pancreatic Cancer Candidate In Animal Models ↗

July 20, 2021

Lantern Pharma Inc (NASDAQ: LTRN) has announced new preclinical data from its ongoing pancreatic cancer collaboration with the Pancreatic Cancer Institute at Fox...

Via Benzinga

62 Biggest Movers From Yesterday ↗

July 21, 2021

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 20, 2021

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock moved upwards by 36.87% to $3.86 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

Lantern Pharma - Using AI to Transform The Cost & Risk of Cancer Drug Development ↗

May 25, 2021

Artificial intelligence is one of the most fascinating and powerful technological advances to come along over the past decade. The idea that we can use machine learning and data...

Via Benzinga

Topics Artificial Intelligence

Earnings Scheduled For May 3, 2021 ↗

May 03, 2021

Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.